仁度生物
(688193)
| 流通市值：12.13亿 | | | 总市值：15.38亿 |
| 流通股本：3156.84万 | | | 总股本：4000.00万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 235,075,162.53 | 242,029,282.79 | 589,909,175.16 | 609,567,016.44 |
| 应收票据及应收账款 | 66,139,797.51 | 72,397,506.47 | 69,704,041.39 | 77,065,621.68 |
| 其中：应收票据 | - | - | 100,000 | 259,948.88 |
| 应收账款 | 66,139,797.51 | 72,397,506.47 | 69,604,041.39 | 76,805,672.8 |
| 应收款项融资 | - | - | 775,788 | 532,680 |
| 预付款项 | 4,534,090.97 | 3,178,498.31 | 3,535,859.85 | 2,640,583.03 |
| 其他应收款合计 | 1,305,312.87 | 986,103.06 | 957,669.44 | 1,100,926.34 |
| 存货 | 24,199,232.67 | 25,185,902.01 | 27,025,375.34 | 28,595,133.59 |
| 其他流动资产 | 83,052,622.83 | 79,603,271.29 | 155,289,654.87 | 129,429,149.4 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 857,082,886.04 | 869,412,855.59 | 887,218,897.39 | 899,141,593.82 |
| 非流动资产: | | | | |
| 固定资产 | 81,000,463.24 | 83,741,005.82 | 84,615,613.09 | 85,796,703.58 |
| 在建工程 | - | 218,830.28 | - | - |
| 使用权资产 | 4,836,903.72 | 5,531,718.39 | 6,226,533.05 | 6,921,347.71 |
| 无形资产 | 466,936.12 | 524,252.53 | 401,568.94 | 449,885.35 |
| 长期待摊费用 | 6,967,344.86 | 7,193,071.1 | 7,814,054.87 | 8,298,077.41 |
| 递延所得税资产 | 13,140,363.09 | 13,471,239.4 | 13,336,729.33 | 12,958,033.21 |
| 其他非流动资产 | 41,800,500 | 41,409,165 | 41,211,665 | 41,150,055 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 148,212,511.03 | 152,089,282.52 | 153,606,164.28 | 155,574,102.26 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,005,295,397.07 | 1,021,502,138.11 | 1,040,825,061.67 | 1,054,715,696.08 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 5,235,321.77 | 3,819,549.55 | 3,905,214.08 | 4,093,721.67 |
| 应付账款 | 5,235,321.77 | 3,819,549.55 | 3,905,214.08 | 4,093,721.67 |
| 合同负债 | 2,883,172.86 | 3,836,598.68 | 3,994,282.14 | 5,576,662.23 |
| 应付职工薪酬 | 9,297,521.84 | 8,952,662.79 | 8,343,554.83 | 12,893,327.03 |
| 应交税费 | 1,124,651.6 | 1,048,360.38 | 1,794,321.93 | 1,547,366.74 |
| 其他应付款合计 | 48,065,737.7 | 52,164,219.48 | 51,876,772.77 | 51,278,886.38 |
| 一年内到期的非流动负债 | 2,574,992.71 | 2,911,213.85 | 2,499,490.83 | 2,925,195.22 |
| 其他流动负债 | 111,353.36 | 139,822.45 | 147,413.51 | 131,793.74 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 69,292,751.84 | 72,872,427.18 | 72,561,050.09 | 78,446,953.01 |
| 非流动负债: | | | | |
| 租赁负债 | 2,288,127.64 | 2,796,556.12 | 3,878,617.7 | 4,090,994.16 |
| 预计负债 | 31,607.43 | 3,143.54 | - | 11,800.78 |
| 递延收益 | 6,403,014.5 | 7,210,111.88 | 8,317,209.26 | 9,424,306.64 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 8,722,749.57 | 10,009,811.54 | 12,195,826.96 | 13,527,101.58 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 78,015,501.41 | 82,882,238.72 | 84,756,877.05 | 91,974,054.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 40,000,000 | 40,000,000 | 40,000,000 | 40,000,000 |
| 资本公积 | 777,482,092.16 | 776,221,863.73 | 774,961,635.3 | 773,701,406.86 |
| 减:库存股 | 35,659,786.74 | 23,378,565.5 | 11,706,268.91 | - |
| 其他综合收益 | -763,277.85 | -103,881.17 | -279,926.95 | -348,602.73 |
| 盈余公积 | 12,924,505.3 | 12,924,505.3 | 12,924,505.3 | 12,924,505.3 |
| 未分配利润 | 133,296,362.79 | 132,955,977.03 | 140,168,239.88 | 136,464,332.06 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 927,279,895.66 | 938,619,899.39 | 956,068,184.62 | 962,741,641.49 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 927,279,895.66 | 938,619,899.39 | 956,068,184.62 | 962,741,641.49 |
| 负债和股东权益合计 | 1,005,295,397.07 | 1,021,502,138.11 | 1,040,825,061.67 | 1,054,715,696.08 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |